Evidence map›Paper›PMID 26042187›Full record

ArticleNew microbes and new infections2015

First data on Pneumocystis jirovecii colonization in patients with respiratory diseases in North Lebanon.

S Khalife, E M Aliouat, C M Aliouat-Denis, N Gantois, P Devos, H Mallat, E Dei-Cas, F Dabboussi, M Hamze, E Fréalle

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Interest of a CommercializedJournal of clinical medicine · 2022
    Article
  3. Article
  4. Molecular diagnosis and genotyping ofCurrent medical mycology · 2019
    Article
  5. A multi-centered study ofCurrent medical mycology · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

S KhalifeBiology and Diversity of Emerging Eukaryotic Pathogens (BDPEE), Pasteur Institute of Lille, Centre for Infection and Immunity of Lille, University of Lille, Lille, France ; Health and Environment Microbiology Laboratory, AZM Centre for Research in Biotechnology and its Application, Doctoral School of Sciences and Technology, Lebanese University, Tripoli, Lebanon.
E M AliouatBiology and Diversity of Emerging Eukaryotic Pathogens (BDPEE), Pasteur Institute of Lille, Centre for Infection and Immunity of Lille, University of Lille, Lille, France.
C M Aliouat-DenisBiology and Diversity of Emerging Eukaryotic Pathogens (BDPEE), Pasteur Institute of Lille, Centre for Infection and Immunity of Lille, University of Lille, Lille, France.
N GantoisBiology and Diversity of Emerging Eukaryotic Pathogens (BDPEE), Pasteur Institute of Lille, Centre for Infection and Immunity of Lille, University of Lille, Lille, France.
P DevosDepartment of Research, Lille University Hospital, Lille, France.
H MallatHealth and Environment Microbiology Laboratory, AZM Centre for Research in Biotechnology and its Application, Doctoral School of Sciences and Technology, Lebanese University, Tripoli, Lebanon.
E Dei-CasBiology and Diversity of Emerging Eukaryotic Pathogens (BDPEE), Pasteur Institute of Lille, Centre for Infection and Immunity of Lille, University of Lille, Lille, France ; Parasitology-Mycology Laboratory of Lille University Hospital Centre & Faculty of Medicine of Lille, University of Lille, Lille, France.
F DabboussiHealth and Environment Microbiology Laboratory, AZM Centre for Research in Biotechnology and its Application, Doctoral School of Sciences and Technology, Lebanese University, Tripoli, Lebanon.
M HamzeHealth and Environment Microbiology Laboratory, AZM Centre for Research in Biotechnology and its Application, Doctoral School of Sciences and Technology, Lebanese University, Tripoli, Lebanon.
E FréalleBiology and Diversity of Emerging Eukaryotic Pathogens (BDPEE), Pasteur Institute of Lille, Centre for Infection and Immunity of Lille, University of Lille, Lille, France ; Parasitology-Mycology Laboratory of Lille University Hospital Centre & Faculty of Medicine of Lille, University of Lille, Lille, France.
Lebanese University · LBInstitut Pasteur de Lille · FRUniversité de Lille · FRCenter for Infection and Immunity of Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pneumocystis colonization may play a role in transmission and local inflammatory response. It was explored in patients with respiratory diseases in North Lebanon. Overall prevalence reached only 5.2% (95% CI 2.13-10.47) but it was higher (17.3%) in the subpopulation of patients with chronic obstructive pulmonary disease (COPD). COPD was the only factor associated with a significantly increased risk of colonization. mtLSU genotyping revealed predominance of genotype 2, identified in five patients (71.4%), including one patient who had co-infection with genotype 3. These first data in North Lebanon confirm Pneumocystis circulation among patients with respiratory diseases and the potential for transmission to immunocompromised patients.

Indexed as

Chronic obstructive pulmonary diseaseLebanonmtLSU genotypePneumocystis colonizationrespiratory diseases

Identifiers

PMID26042187
PMCPMC4442690
OpenAlexW1986747413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.